title: [Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts].
abstract: Chemokines promote leukocyte traffic into the site of inflammation. It depends on the repertoire of chemokines synthesized locally, and the temporal expression of chemokine receptors on leukocytes among them lymphocytes B and T which play crucial role in the pathogenesis of autoimmune diseases for example in systemic lupus erythematosus (SLE). RANTES (regulated upon activation in normal T cells expressed and secreted) is chemokine influencing T cells and BLC 1 (B-lymphocyte chemoattractant 1) is chemokine which affects B cells. The aim of the study was to evaluate serum concentration of the above mentioned chemokines in treated SLE patients and to analyze the relationships between their concentration in patients group and the control one. Another aim of our study was to assess the relationships between serum levels of these chemokines and the total peripheral blood leukocyte count and between serum levels of these chemokines and absolute peripheral blood counts of the individual forms of these cells in SLE patients.
  
  
  METHODS
  Serum levels of RANTES and BLC 1 were determined in 48 treated women with SLE and mild-to-moderate disease severity. The results were compared between the total SLE group and the control (29 healthy women). The correlation between chemokines and between their levels and peripheral blood leukocyte count were evaluated. The relationships between the analyzed chemokines were also determined in the control group.
  
  
  RESULTS
  Lower level of RANTES in serum was revealed in patients with SLE compared to the control and the tendency to higher concentration of BLC 1 in serum was observed. No relationships were observed between the levels of these chemokines both in the SLE patients and in the control group. Whereas the negative correlations between BLC 1 and total leukocyte count and BLC 1 and absolute number of neutrophils were found without such correlation between BLC 1 the subgroup of patients with concomitant neutropenia.
  
  
  CONCLUSIONS
  We suggest that in treated patients with SLE lowered level of RANTES and tendency to higher level of BLC 1 is observed which have not any connections with the peripheral blood leukocyte counts and individual forms of these cells counts.
authors.affiliation: Slaski Uniwersytet Medyczny w Katowicach, Koło Naukowe przy Katedrze i Klinice Chorób Wewnetrznych, Autoimmunologicznych i Metabolicznych.
authors.forename: Maria
authors.initials: M
authors.lastname: Kopczyńska
authors.forename: Andrzej
authors.initials: A
authors.lastname: Franek
authors.forename: Edward
authors.initials: E
authors.lastname: Błaszczak
authors.forename: Justyna
authors.initials: J
authors.lastname: Dworak
authors.forename: Przemysław
authors.initials: P
authors.lastname: Kopczyński
authors.forename: Antoni
authors.initials: A
authors.lastname: Hrycek
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D018946:Chemokine CCL5 / Q000097:blood*; D054382:Chemokine CXCL13 / Q000097:blood*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000097:blood* / Q000188:drug therapy; D012016:Reference Values
chemical_list: D015415:Biomarkers; C110663:CXCL13 protein, human; D018946:Chemokine CCL5; D054382:Chemokine CXCL13